Oiva Health Danmark ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.7% 1.7% 2.2% 1.2% 1.2%  
Credit score (0-100)  72 71 66 80 81  
Credit rating  A A BBB A A  
Credit limit (kDKK)  6.3 7.5 0.4 373.4 370.6  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  4,118 5,463 4,866 10,877 10,798  
EBITDA  2,116 3,076 2,097 7,037 6,029  
EBIT  778 1,514 160 4,714 3,296  
Pre-tax profit (PTP)  740.1 1,498.8 119.7 4,637.7 3,253.1  
Net earnings  724.1 1,417.8 81.7 3,616.2 2,389.1  
Pre-tax profit without non-rec. items  740 1,499 120 4,638 3,253  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  14.6 6.3 0.0 0.0 0.0  
Shareholders equity total  6,699 8,117 8,199 11,815 14,204  
Interest-bearing liabilities  1,782 188 2,003 1,089 274  
Balance sheet total (assets)  15,682 18,839 19,774 22,153 26,091  

Net Debt  1,760 173 1,980 826 -3,003  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  4,118 5,463 4,866 10,877 10,798  
Gross profit growth  -7.9% 32.7% -10.9% 123.5% -0.7%  
Employees  4 5 5 6 7  
Employee growth %  0.0% 25.0% 0.0% 20.0% 16.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  15,682 18,839 19,774 22,153 26,091  
Balance sheet change%  8.8% 20.1% 5.0% 12.0% 17.8%  
Added value  2,115.6 3,075.8 2,097.5 6,651.5 6,028.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -437 653 46 -554 -1,176  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  18.9% 27.7% 3.3% 43.3% 30.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  5.2% 8.8% 0.9% 22.5% 13.7%  
ROI %  7.1% 13.4% 1.4% 31.8% 18.5%  
ROE %  11.4% 19.1% 1.0% 36.1% 18.4%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  42.7% 43.1% 41.5% 53.3% 54.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  83.2% 5.6% 94.4% 11.7% -49.8%  
Gearing %  26.6% 2.3% 24.4% 9.2% 1.9%  
Net interest  0 0 0 0 0  
Financing costs %  2.0% 1.5% 4.4% 5.2% 6.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.5 0.5 0.3 0.6 0.8  
Current Ratio  0.5 0.5 0.3 0.6 0.8  
Cash and cash equivalent  21.6 14.2 23.2 263.8 3,277.7  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -3,345.2 -3,942.6 -5,920.1 -2,055.9 -1,541.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  529 615 419 1,109 861  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  529 615 419 1,173 861  
EBIT / employee  194 303 32 786 471  
Net earnings / employee  181 284 16 603 341